In a recent announcement to the public, Merck – a United States pharmaceutical giant – will be cutting 8,500 jobs as part of a business strategy to become more competitive in their field.
An article by CNN reports that Merck also plans to cut $2.5 billion from its annual operating costs by the year 2015. The first step, cutting 8,500 jobs, comes in addition to the previous 7,500 jobs that were cut in 2011 and 2012. ...
continue reading...
GlaxoSmithKline announced that its once-weekly diabetes drug called albiglutide was effective in late-stage clinical trials.
A story in Reuters about the announcement speculates that despite those results, the drug may face challenges in an increasingly competitive market for diabetes drugs. But some of the newer types of diabetes drugs such as Januvia and Byetta have generated health concerns recently.
The medical journal BMJ has published an investigation about the diabetes drugs called ...
continue reading...
The U.S. Food and Drug Administration has approved Johnson & Johnson’s drug Invokana, which will be used to treat type 2 diabetes.
According to the New York Times, Invokana is the first of a new class of diabetes medication. It causes blood sugar to be excreted in the urine, as opposed to many other drugs on the market that work by affecting the supply or use of insulin.
Last year, the FDA ...
continue reading...
A number of prominent nutritionists have reiterated a warning about a potential link between red meat consumption and Type 2 diabetes, the Los Angeles Times reports.
Although diabetes is manageable, the Mayo Clinic says it can eventually cause disabling or even life-threatening complications.
And a growing body of evidence links some diabetes treatments – including the drugs Byetta and Januvia — to a potentially deadly inflammation of the pancreas called pancreatitis, and ...
continue reading...
Pancreatic Cancer UK, a charity group based in the United Kingdom, has joined the American Diabetes Association in calling for companies to release information about a potential link between some diabetes medication and pancreatic cancer.
Pressure on the companies is intensifying after Channel 4 Dispatches and the medical journal BMJ reported the results of a joint investigation, BMJ says.
That investigation added to a growing body of evidence suggesting a potential link ...
continue reading...
An investigation in the medical journal BMJ faults the U.S. Food and Drug Administration for its tepid response to reports that diabetes drugs including Byetta and Januvia may be linked to pancreatitis and pancreatic cancer.
Both the FDA and the European Medicines Agency are conducting investigations into that class of drugs, called incretin mimetics, the story says. And both agencies have confirmed that their own analyses show increased reporting or signals ...
continue reading...
